Non-Invasive Assessment of Pulmonary Vasculopathy

Right heart catheterization remains necessary for the diagnosis of pulmonary hypertension and, therefore, prognostic evaluation patients with chronic failure. The non-invaSive Assessment Pulmonary vasculoPathy in Heart failure (SAPPHIRE) study was designed to assess feasibility and relevance a non-invasive artery vasculature hypertension. Patients will undergo right catheterization, cardiac resonance imaging, function test order identify structural functional parameters allowing identification combined pre- postcapillary hypertension, correlate these findings hemodynamic data.